Selective ubiquitination of calmodulin by UBC4 and a putative ubiquitin protein ligase (E3) from Saccharomyces cerevisiae  by Parag, Hadas A. et al.
Volume 325, number 3. 242-246 FEB.5 12632 
8 1993 Federation of European Btochenucal Societies 00145793/93/$6.00 
July 1993 
Selective ubiquitination of calmodulin by UBC4 and a putative ubiquitin 
protein ligase (E3) from Saccharomyces cerevisiae 
Hadas A. Parag, Deborah Dimitrovsky, Bilha Raboy and Richard G. Kulka 
Department of Biological Ckemistry Tke Alexander Silbermun Institute qf’ Life Sciences. Tke Hebrew Universit~~ oj Jerusalem. 
Jerusalem 91904, hurl 
Received 18 April 1993 
A putative ubiquitm protein ligase (E3-CaM) whtch cooperates wtth UBC4 in selecttvely ubtquttmatmg calmoduhn has been partially purified from 
Succharonzyces cerevixae. Ca” was required for this activtty and monoubtquitmated calmodulin was the mam product of the reactton. The apparent 
K,,, of E3-CaM for calmoduhn was approximately 1 PM which is of the same order of magmtude as the concentration of calmodulin m yeast cells 
Protems which are good substrates for other E3s (E3a or E3-R) were not ubiquitinated by E3-CaM Lower but significant activittes of E3-CaM 
were observed when UBCl replaced UBC4, 
Ubtquitin: Calmoduhn: UBC4: Ubiquttin protem hgase; Sacc/~aron~~cc~s ererlsrcrr 
1. INTRODUCTION 
In eukaryotic cells Ca’+ fluxes play an important role 
in modulating diverse cellular functions. One of the 
mediators of the Ca’+ signal is calmodulin (CaM)‘, a 
small calcium-binding protein. The binding of Ca” to 
CaM causes a change in its conformation which pro- 
motes its attachment to a wide variety of target proteins 
whose activity it modulates (reviewed in [ 1,2]). In Sac- 
ckaronqlces cerevisiae the gene encoding CaM (CMDI) 
is essential [3,4], and Ca”/CaM-dependent protein ki- 
nases and phosphatases have been identified [.5,6], but 
the physiological functions of CaM in this organism are 
still unknown [7]. 
CaM from S. crrerisiae, Dictyostelium. Neurospora, 
spinach and mammals can be conjugated to ubiquitin 
by reticulocyte extracts [S-12]. Enzymes catalyzing the 
Ca”-dependent ligation of ubiquitin to CaM from yeast 
or mammals have also been found in extracts of S. 
cerevisiae [ 131 as well as in extracts of mammalian tis- 
sues other than reticulocytes [14]. Ubiquitin is a 76 res- 
idue eukaryotic protein whose multiple cellular func- 
tions involve its covalent ligation to other proteins. This 
is usually the first step in the degradation of the target 
proteins by an intracellular proteolytic pathway (re- 
viewed in [ 15,161). The ligation of ubiquitin to its target 
proteins involves three enzymatic steps. In the first step 
ubiquitin is linked via a thioester bond to the ubiquitin 
activating enzyme El. The second step is the transfer of 
ubiquitin from El to one of a family of ubiquitin-conju- 
gating enzymes (UBC or E2). Some of the E3 enzymes 
are able to conjugate ubiquitin to particular target pro- 
teins without the participation of additional factors [ 17- 
19] but the conjugation of ubiquitin to other target pro- 
teins requires the intervention of yet another class of 
enzymes known as ubiquitin protein ligases or E3s [20- 
24]. Since previous in vitro studies on CaM ubiquitina- 
tion [S-14] have been carried out with crude enzyme 
systems, they do not indicate whether CaM is recog- 
nized by an E2 alone or requires the additional partici- 
pation of an E3 enzyme. Here we present evidence for 
the presence in S. cerevisiar of a putative E3 enzyme 
which cooperates with the E2 enzyme UBC4 [25] to 
ubiquitinate CaM in the presence of Ca’+. 
2. MATERIALS AND METHODS 
?. 1. Prepuruflon of Fraction II 
Correspondence address R.G Kulka, Dept. of Biological Chemistry, 
Institute of Life Sciences. The Hebrew University of Jerusalem. 
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Abbrewtions CaM, calmodulin: DTT, dithiothrettol, EGTA, ethyl- 
ene glycol-bts-@-ammoethyl ether)N.N.N ‘N ‘-tetraacetr acid; PMSF, 
phenylmethyl sulfonyl fluoride. 
Yeast cells (stram SUB325 [23], kindly provtded by D. Finley) 
grown m a fermentor were suspended m 1 vol. of buffer consistmg of 
25 mM Tris-HCI pH 7 8, 5 mM EDTA, 1 mM DTT and 0.5 mM 
PMSF and broken m a cooled Matcu Gaulin Homogemzer at 8000 
psi. After adjustmg the pH to 7.0 with Trts base, the extract was 
fractionated by ammonium sulfate precipttatton. The fraction precip- 
itating between 25% and 70% saturation was collected by centrtfuga- 
tton, suspended in a mimmal volume of 50 mM sodium phosphate 
buffer pH 7 5 and 2 mM mercaptoethanol and dialyzed against 100 
~01s. of the same buffer, This fractton was ahquoted and stored at 
-20”. Ahquots were frachonated on a DEAE-cellulose (Whatman 
DE52) column by the following modtfication of previously described 
methods [17.20]. The sample, containing 3 mg of protein per ml of 
column. was loaded and the column was washed wtth 1 5 ~01s. of 
3 mM phosphate buffer pH 7.0 contauung 20 mM KCl, 5 mM EDTA 
and 1 mM DTT ‘Fractton II’ was eluted with 3 ~01s. of 20 mM Trts 
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pH 7.2, containing 0.5 M KCl, 5 mM EDTA and 1 mM DTT and was 
precipitated with ammonium sulfate at 70% saturation. The precipi- 
tate was suspended in a minimal volume of a buffer containing 20 mM 
Tris-HCl pH 7.5, 5% glycerol, 5 mM MgC&, 5 PM ATP, 0.2 mM DTT 
and 1 mM EDTA and dialyzed twice against 40 vols. of the same 
buffer. 
2.2. Phenyl-Sepharose chromatography 
A sample of Fraction II was mixed with an equal volume of 100 mM 
sodium phosphate pH 7.0 containing 2 M ammonium sulfate, 4 mM 
DTT and 2 mM EGTA and loaded on a phenyl-Sepharose CL4B 
column eqmlibrated with a 50 mM so&urn phosphate pH 7.0 and 
1 M ammonium sulfate. The column was washed with 3 ~01s. SO mM 
phosphate buffer pH 7.0 containing 1 M ammonium sulfate and 2 mM 
DTT and eluted with steps of 1.5 ~01s. each of 50 mM sodium phos- 
phate pH 7.0 plus 2 mM DTT containing successively 0.3 M, 0.15 M 
and no ammonium sulfate. Tins was followed by 1.5 ~01s. of 15 mM 
phosphate buffer pH 7.0 plus 2 mM DTT and 16.5 ~01s. of 5 mM 
phosphate buffer pH 7.0 plus 2 mM DTT. The ubiquitination activity 
on CaM (dependent on UBC4) was eluted at 5 mM phosphate and the 
active fractions were dialyzed agamst 50 mM Tris-HCl pH 7.5, 5% 
glycerol and 4 mM DTT. 
2.3. Calmodulin-agurose chromatography 
A calmodulin-agarose column (Sigma) was equilibrated with buffer 
A (50 mM Tris-HCl pH 7.5, 1 mM DTT, 1 &ml ovalbumin) supple- 
mented with 0.1 mM CaCl, and 100 ,ug/ml ovalbumin. The sample in 
Buffer A plus 0.1 mM CaClz was applied and the column was washed 
with 10 ~01s. of buffer A containing 0.1 mM CaCI, followed by 10 ~01s. 
of the same buffer containmg 1 M KC1 (KC1 eluate). After washing 
with 10 ~01s. of Buffer A (wIthout CaCI,,) the column was eluted with 
10 vols. of Buffer A containing 1 mM EGTA (EGTA eluate) followed 
by 10 ~01s. of Buffer A supplemented with 1 mM EGTA and 1 M KC1 
(KC1 + EGTA eluate). Fractions were concentrated on Centrlprep 30 
(Armcon) ultrafilters and washed twice with 10 ~01s. of Buffer A. 
Samples of fractions were subjected to electrophoresis and protems 
were detected by silver staining [26]. 
2 4. FPLC on Mono-Q 
A Mono-Q column (Pharmacia) was eqmlibrated in a buffer con- 
tammg 50 mM Tris-HCI pH 7.5, 5% glycerol, 0.2 mM EDTA and 
2 mM DTT. The EGTA eluate from the calmoduhn agarose column 
was applied and 0.5 ml fractions were collected in a O-l M KC1 
gradient. Samples were collected into tubes containing 5 pg of ovalbu- 
mm. UBC4-dependent activity on CaM was eluted at 150-210 mM 
KCl. Samples were dialyzed against the buffer used to equilibrate the 
column and concentrated with Centricon 30 ultrafilters. 
2.5. Preporation of El and E2s 
El was purified from yeast as described previously [23]. UBCl, 
UBC4. RAD6 and CDC34 were prepared from extracts of E. coli 
containing the appropriate expression vectors (generously provided by 
S. Jentsch) essentially as described in an earlier paper [23] except that 
the UBC4-containing extract was used without further purification. 
2.6. Ubiquitin coqugation assal 
The conjugation of [“51]ubiquitin to bovine CaM (Sigma) was de- 
tected as described previously [23]. The standard assay system (12.5 
~1) contained 2.5 pg bovine calmodulin (Sigma), and approximately 
0.1 pmol El, 2 pmol of UBC4 and varying amounts of fractions 
contaming E3-CaM. Additional components were: 50 mM Trls-HCI 
pH 7.6, 5 mM MgCl,, 2 mM DTT. 2 mM ATP, 10 mM creatine 
phosphate, 2.5 pg creatine kinase, 7 pmol of [“‘I]ubiqmtin (2 x 10’ 
cpm) and 10 fig/ml each of the following peptide protease inhibitors: 
leupeptin, pepstatin, chymostatin. bestatin. and antipain. After incu- 
bation for 1 h at 3O”C, the reaction was stopped with SDS electropho- 
resis sample buffer and the samples were heated for 3 mm in a boiling 
water bath. SDS-PAGE electrophoresis and autoradiography were 
performed as described earlier [23]. 
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Fig. 1. E3-CaM activity of fractions eluted from a CaM-agarose col- 
umn. Activity was detected by incubating [“‘Ilubiquitin and CaM with 
a sample of the fraction supplemented with El and UBC4. followed 
by SDS-PAGE electrophoresis and autoradiography. Lane 1, pooled 
phenyl-Sepharose E3-CaM enriched fractions loaded on column; lane 
2, unadsorbed fraction plus CaM: lane 3, unadsorbed fraction, with- 
out CaM: lane 4. KC1 eluate plus CaM; lane 5. KC1 eluate without 
CaM; lane 6. EGTA eluate plus CaM; lane 7, EGTA eluate wlthout 
CaM; lane 8. KCI plus EGTA eluate plus CaM. 
3. RESULTS 
We have partially purified a putative E3 (hereafter 
referred to as E3-CaM) from Saccharomyces cerevisiae. 
which catalyzes the ubiquitination of bovine calmod- 
ulin. Since preliminary experiments showed that E3- 
CaM acts preferentially with UBC4, enzyme activity 
was assayed in the presence of added E 1 and UBC4 and 
was detected by the formation of a 29 kDa band corre- 
sponding to mono-ubiquitinated bovine calmodulin 
[13]. A lower molecular weight band (25 kDa) which 
was found in almost all fractions is the putative 
monoubiquitinated derivative of UBC4. Fraction II, 
prepared by a modification of previous methods 
[ 17,20,23] was subjected to hydrophobic chromatogra- 
phy on phenyl-Sepharose. E3-CaM was strongly bound 
to the phenyl-Sepharose column and was eluted at low 
salt concentrations (not shown). It has previously been 
shown that CaM ubiquitination by yeast extracts is 
Ca’+-dependent [13]. This was exploited to further pu- 
rify E3-CaM from pooled phenyl-Sepharose fractions 
on a CaM-agarose column (Fig. 1). E3-CaM was re- 
tained on the CaM-agarose column in the presence of 
Ca” and 1 M KC1 and was eluted with EGTA. Silver 
staining showed that the EGTA eluate contained multi- 
ple protein bands none of which could be identified as 
E3-CaM (not shown). The E3-CaM-enriched fractions 
produced monoubiquitinated CaM as well as high mo- 
lecular weight ubiquitin conjugates (Fig. 1). Since the 
formation of these high molecular weight conjugates 
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Fig. 2. E3-CaM activity of fractions eluted from a Mono-Q column. 
E3-CaM activity was detected by the conjugation of [‘?]ubiquitin to 
CaM as described in section 2 and Fig. 1. Lane 1, CaM-agarose EGTA 
eluate applied to column. The other lanes contained fractrons eluted 
at the following KC1 concentrations: lane 2, 60P110 mM; lane 3. 
110P150 mM; lane 4, 150-210 mM, lane 5. 210-250 mM; lane 6, 
250-310 mM; lane 7, 310-390 mM: lane 8, 390450 mM: lane 9, 
450-510 mM; lane 10, assay system without added fraction. 
was independent of added CaM. they apparently repre- 
sented conjugates of endogenous substrates with ubi- 
quitin. The EGTA eluate from the CaM-agarose col- 
umn was further purified by FPLC on a Mono-Q col- 
umn (Fig. 2) from which E3-CaM was eluted between 
1 lo- 250 mM KCl. Even the purest UBCbdependent 
CaM- E3 fractions contained many different proteins 
none of which could be identified as CaM-E3 (not 
shown). The high molecular weight conjugates were 
greatly reduced in E3-CaM-containing fractions from 
the Mono-Q column (Fig. 2). We were unable to deter- 
mine the overall degree of purification of E3-CaM since 
E3-CaM activity in Fraction II could not be determined 
because of high background activity. In addition, pro- 
tein could not be determined in the Mono-Q column 
fractions which were collected into tubes containing 
ovalbumin to stabilize the enzyme. E3-CaM was puri- 
fied about lo-fold in the CaM-Agarose step. 
The apparent K, of E3-CaM for CaM was approxi- 
mately 1 ,uM which is of the same order of magnitude 
as the concentration of CaM in yeast cells [4]. In our 
experiments only monoubiquitinated CaM could be de- 
tected whereas in previously published experiments [ 131 
both singly and multip!y ubiquitinated species of CaM 
were formed. This apparent discrepancy could be due 
to differences in the reaction conditions but may also 
indicate that an additional component present in the 
crude system but not in ours, such as an additional E2, 
is required for multiubiquitination. 
Fig. 3A shows that CaM is not ubiquitinated unless 
El, E2 (UBC4) and E3 (E3-CaM) are all present. Weak, 
but distinct, E3-CaM activity was observed when UBC4 
was replaced by UBCl (Fig. 3B). Like the activity with 
UBC4 this activity was Ca”-dependent. Traces of activ- 
ity were also observed when RAD6 replaced UBC4 
(Fig. 3B). This activity was only partially sensitive to 
EGTA and may have been due, at least in part, to 
contamination with E3-R. The RAD6-dependent E3 
(E3-R) described previously [23] had appreciable CaM- 
ubiquitinating activity which was insensitive to EGTA 
(Raboy. unpublished experiments). CDC34 did not co- 
operate detectably with E3-CaM (Fig. 3B). The ubi- 
quitin conjugates at about 70 kDa which are also 
formed in the absence of CaM (not shown) are probably 
various species of self-ubiquitinated CDC34. 
E3-CaM activity was inhibited by EGTA and re- 
stored by the addition of excess Ca’+ (Fig. 4). This could 
mean that E3-CaM itself requires Ca” for activity or. 
more likely, that the substrate of E3-CaM is Ca”- 
bound CaM rather than the free form. E3-CaM activity 
was completely inhibited by 10,uM M5 (kindly donated 
by Y. Salomon). MS is an 18 residue synthetic peptide 
modelled after the CaM-binding domain of rabbit skel- 
etal muscle myosin light chain kinase [27]. Trifluo- 
perazine (30yM), which is thought to bind to the hydro- 
phobic regions of CaM exposed upon Ca’+ binding 
[1,28], also inhibited CaM ubiquitination by E3-CaM. 
E3-CaM had no detectable activity on substrates of 
E3a [21] or E3-R [23], namely, /%lactoglobulin, /?- and 
Ic-casein (Fig. 5) a-casein and oxidized ribonuclease 
(not shown). Thus, as far as can be deduced from these 
experiments, E3-CaM seems to be specific for CaM. 
4. DISCUSSION 
Previous experiments in other laboratories showed 
that CaM is ubiquitinated in a Ca”-dependent manner 
by cell extracts [9-141 but the species of E2 involved as 
well as the requirement for an E3 were unknown. Here 
we describe a putative E3 which cooperates with UBC4 
in ubiquitinating CaM in the presence of Ca’+. The 
UBC4 requirement of E3-CaM contrasts with the 
RAD6 requirement of other E3s described earlier, 
namely, UBRl [24], E3a [21], and E3-R [23]. In vivo 
experiments demonstrate an important role for UBC4 
in the degradation of abnormal proteins but neither 
T 
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I234 123 4 
Fig. 3. Requirement for E3-CaM and a specific E2 in the CaM ubi- 
quitination system. E3-CaM was from pooled Mono-Q fracttons. (A) 
Lane 1. El omitted; lane 2, E2 (UBC4) omitted; lane 3, E3 (E3-CaM) 
omnted; lane 4. complete system. (B) El plus E3-CaM supplemented 
with: lane 1, 0.8 pmol UBCl; lane 2 1.9 pmol UBC4: lane 3.0.9 pmol 
RAD6: lane 4, 1.9 pmol CDC34. 
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Fig. 4. Dependence of E3-CaM activity on Ca*‘. The reaction mixture 
contained CaM-agarose-purified E3-CaM. Lane l,O.l mM Ca”. lane 
2,0.1 mM Ca*’ plus 0.5 mM EGTA; lane 3, 1.6 mM Ca” plus 0.5 mM 
EGTA. 
unassisted ubiquitination of specific target proteins by 
UBC4 in vitro nor ubiquitination assisted by E3 have 
been observed previously. 
Although endogenous CaM has been shown to be 
ubiquitinated in rabbit tissue extracts in vitro [29], the 
existence of CaM ubiquitination in vivo has not yet 
been demonstrated, nor, if it exists, are there any clues 
as to its function. The rates of decay of CaM levels upon 
transfer to glucose in cmdl cells bearing a galactose- 
induced CMDl gene do not reveal a rapid turnover of 
CaM in yeast [4]. However, CaM ubiquitination and 
degradation may be activated in vivo only under special 
circumstances when intracellular Ca2’ levels are ele- 
vated. It may be significant that the ubiquitin conjugat- 
ing enzymes which cooperate with E3-CaM are UBC4 
and UBCl which have overlapping functions in protein 
degradation [25]. Another interesting possibility is that 
ubiquitination modulates CaM function rather than 
Substrate 
E3 
kDa 
67- 
45- 
29- 
,Xj +HMW 
+U b-h M 
I23456 
[13] Jennissen, H.P., Botzet, G.. Majetschak, M., Laub, M. Zie- 
genhagen. R. and Demiroglou, A. (1992) FEBS Lett. 296. 
51-56. 
[14] Jennissen, H.P. and Laub, M. (1988) Biol. Chem. Hoppe-Seyler 
369. 132551330. 
Fig. 5. Substrate specificity. E3-CaM was from pooled Mono-Q col- 
umn fractions. Substrates, 2 pg each were added as indicated. Lane 
1, CaM with E3-CaM; lane 2, &lactoglobulin with E3-CaM; lane 3, 
p-lactoglobulin without E3-CaM; lane 4, Ic-casein with E3-CaM, lane 
5, rc-casein without E3CaM; lane 6, no additions. [16] Jentsch, S. (1992) Annu. Rev. Genet. 26, 177-205. 
[15] Hershko, A. and Ciechanover, A. (1992) Annu. Rev. Brochem. 
61, 761-807. 
promoting its breakdown. When Ca”-bound CaM was 
associated with one of its target proteins, phosphorylase 
kinase, it was resistant to ubiquitination [lo]. CaM ubi- 
quitination was also inhibited by the peptide inhibitor 
M5 which mimics the CaM-binding domain of rabbit 
skeletal muscle myosin light chain kinase [27]. Appar- 
ently the structural features of Ca*‘-CaM recognized by 
the ubiquitination system were masked by binding to its 
target molecules. This raises the possibility that E3- 
CaM may bind to CaM by means of an amphiphatic 
a-helix in a similar manner to that of CaM target pro- 
teins [2,30,31]. Alternatively, E3-CaM may interact by 
some other mechanism with the hydrophobic pockets of 
Ca2’-CaM which would be masked by binding to M5 
or to trifluoperazine. If the ubiquitination site on CaM 
is at or near the target-binding groove of CaM [30,31], 
the bound ubiquitin could modulate the interaction of 
CaM with its targets. Since CaM ubiquitination did not 
cause the release of bound Cal’, ([9] and our experi- 
ments, not shown), it is unlikely that ubiquitination 
affects CaM function by modulating Ca’+ binding. The 
specificity of E3-CaM for Ca’+-CaM strongly suggests 
an in vivo role for CaM ubiquitination but further in- 
vestigation is required to determine what this is. 
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